GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
Clinical trial NCT04979663 · UNKNOWN
Trial details
- NCT number
- NCT04979663
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.